Home > News > Harvard Is Licensing More Than 50 Patents to a Nanotechnology Start-Up
June 3rd, 2007
Harvard Is Licensing More Than 50 Patents to a Nanotechnology Start-Up
George M. Whitesides, a Harvard University chemist, is a renowned specialist in nanotechnology, a field built on the behavior of materials as small as one molecule thick. But there is nothing tiny about the patent portfolio that Harvard has amassed over the last 25 years based on work in his lab.
Today, Harvard and Nano-Terra Inc., a company co-founded by Professor Whitesides, plan to announce the exclusive licensing for more than 50 current and pending Harvard patents to Nano-Terra. The deal could transform the little-known Nano-Terra into one of nanotechnology's most closely watched start-ups.
"It's the largest patent portfolio I remember, and it may be our largest ever," said Isaac T. Kohlberg, who has overseen the commercialization of Harvard's patent portfolio since 2005. Nano-Terra, based in Cambridge, Mass., said that the patent filing and maintenance costs alone top $2 million.
Harris & Harris Group Notes the Receipt of Proceeds From the Sale of Molecular Imprints' Semiconductor Business to Canon April 22nd, 2014
Progress made in developing nanoscale electronics: New research directs charges through single molecules April 21st, 2014
'Exotic' material is like a switch when super thin April 18th, 2014
Scientists open door to better solar cells, superconductors and hard-drives: Research enhances understanding of materials interfaces April 14th, 2014
Gold nanoparticles help target, quantify breast cancer gene segments in a living cell April 23rd, 2014
Economics = MC2 -- A portrait of the modern physics startup: Successful companies founded by physicists often break the Silicon Valley model, according to new American Institute of Physics report April 23rd, 2014
Study finds long-term survival of human neural stem cells transplanted into primate brain April 23rd, 2014
High-Performance, Low-Cost Ultracapacitors Built with Graphene and Carbon Nanotubes: Future devices based on technology could bridge gap between batteries and conventional capacitors in portable electronics and hybrid electric vehicles April 23rd, 2014
Harris & Harris Group Notes Mersana's Collaboration Agreement With Subsidiary of Takeda Pharmaceutical Co. April 8th, 2014
Nanoparticles cause cancer cells to self-destruct April 3rd, 2014
A*STAR's Simtech collaboration agreements to accelerate the growth and development of the microfluidics industry April 1st, 2014
Dolomite releases novel droplet-on-demand sequencing and droplet generation microfluidic system April 1st, 2014